Yihebali Chi1, Feng Du1, Hong Zhao1, Jin-Wan Wang1, Jian-Qiang Cai1. 1. Yihebali Chi, Feng Du, Hong Zhao, Jin-Wan Wang, Jian-Qiang Cai, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Abstract
AIM: To analyze the clinicopathologic characteristics and prognostic factors of rectal neuroendocrine tumors. METHODS: The records of 48 patients with rectal neuroendocrine tumors who were treated at the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, from March 2004 to September 2009 were retrospectively reviewed. The clinicopathological data were extracted and analyzed, and patients were followed-up by telephone or follow-up letter to determine their survival status. Follow-up data were available for all 48 patients. Uni- and multivariate Cox regression analyses were performed to determine the prognostic factors significantly associated with overall survival. RESULTS: The tumors occurred mostly in the middle and lower rectum, and the most prominent symptoms experienced by patients were hematochezia and diarrhea. The median distance between the tumors and the anal edges was 5.0 ± 2.257 cm, and the median diameter of the tumors was 0.8 ± 1.413 cm. The major pathological type was a typical carcinoid tumor, which accounted for 93.8% (45/48) of patients. Tumor-node-metastasis (TNM) stages I, II, III and IV tumors accounted for 78.8%, 3.9%, 9.6% and 7.7% of patients, respectively. The main treatment method, in 72.9% (35/48) of patients, was transanal extended excision. The 1-, 3- and 5-year survival rates of the whole group of patients were 100%, 93.7%, and 91.3%, respectively. Univariate analysis showed that age (P = 0.032), tumor diameter (P < 0.001), histological type (P < 0.001), TNM stage (P < 0.001), and surgical approach (P = 0.002) were all prognostic factors. On multivariate analysis, only the pathological type was shown to be an independent prognostic factor (HR = 2.797, 95%CI: 1.676-4.668, P = 0.004). CONCLUSION: In patients with rectal neuroendocrine tumors, TNM stage I is the most common stage found, and lymph node or distant metastases are rarely seen. The pathological type of the tumor is an independent prognostic factor.
AIM: To analyze the clinicopathologic characteristics and prognostic factors of rectal neuroendocrine tumors. METHODS: The records of 48 patients with rectal neuroendocrine tumors who were treated at the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, from March 2004 to September 2009 were retrospectively reviewed. The clinicopathological data were extracted and analyzed, and patients were followed-up by telephone or follow-up letter to determine their survival status. Follow-up data were available for all 48 patients. Uni- and multivariate Cox regression analyses were performed to determine the prognostic factors significantly associated with overall survival. RESULTS: The tumors occurred mostly in the middle and lower rectum, and the most prominent symptoms experienced by patients were hematochezia and diarrhea. The median distance between the tumors and the anal edges was 5.0 ± 2.257 cm, and the median diameter of the tumors was 0.8 ± 1.413 cm. The major pathological type was a typical carcinoid tumor, which accounted for 93.8% (45/48) of patients. Tumor-node-metastasis (TNM) stages I, II, III and IV tumors accounted for 78.8%, 3.9%, 9.6% and 7.7% of patients, respectively. The main treatment method, in 72.9% (35/48) of patients, was transanal extended excision. The 1-, 3- and 5-year survival rates of the whole group of patients were 100%, 93.7%, and 91.3%, respectively. Univariate analysis showed that age (P = 0.032), tumor diameter (P < 0.001), histological type (P < 0.001), TNM stage (P < 0.001), and surgical approach (P = 0.002) were all prognostic factors. On multivariate analysis, only the pathological type was shown to be an independent prognostic factor (HR = 2.797, 95%CI: 1.676-4.668, P = 0.004). CONCLUSION: In patients with rectal neuroendocrine tumors, TNM stage I is the most common stage found, and lymph node or distant metastases are rarely seen. The pathological type of the tumor is an independent prognostic factor.
Authors: Dong Hyun Kim; Jin Ha Lee; Yoon Jin Cha; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Hoguen Kim; Won Ho Kim; Sung Pil Hong Journal: Dig Dis Sci Date: 2013-12-10 Impact factor: 3.199
Authors: Ferga C Gleeson; Michael J Levy; Eric J Dozois; David W Larson; Louis Michel Wong Kee Song; Lisa A Boardman Journal: Gastrointest Endosc Date: 2014-01-23 Impact factor: 9.427
Authors: Ryaz Chagpar; Yi-Ju Chiang; Yan Xing; Janice N Cormier; Barry W Feig; Asif Rashid; George J Chang; Y Nancy You Journal: Ann Surg Oncol Date: 2012-12-01 Impact factor: 5.344
Authors: Brett Weinstock; Stephen C Ward; Noam Harpaz; Richard R P Warner; Steven Itzkowitz; Michelle Kang Kim Journal: Neuroendocrinology Date: 2013-11-05 Impact factor: 4.914
Authors: Hans Scherübl; Brigitte Streller; Roland Stabenow; Hermann Herbst; Michael Höpfner; Christoph Schwertner; Joachim Steinberg; Jan Eick; Wanda Ring; Krishna Tiwari; Sören M Zappe Journal: World J Gastroenterol Date: 2013-12-21 Impact factor: 5.742
Authors: Jae Hwang Cha; Da Hyun Jung; Jie-Hyun Kim; Young Hoon Youn; Hyojin Park; Jae Jun Park; Yoo Jin Um; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Hyun Jung Lee Journal: Sci Rep Date: 2019-03-20 Impact factor: 4.379